Accelerate transfer of life-science research into clinical practice. Scientific excellence combined with societal/patient benefits. 15+ year investment horizon for biomedical development.
Auto-detected from Carma Fund's website.
Founder of CARMA FUND, economist with extensive venture capital experience including CEO of Future Capital and Partner at Creathor Venture.
Founding team member of CARMA FUND, biologist with PhD from University of Cambridge, experienced in biotech business development and company founding.
Founder of CARMA FUND with background in molecular biology, PhD from Max Planck Institute, experienced CEO and technology transfer executive.
Immunobiologist and drug discovery expert with 25+ years in academia, biotech and pharma R&D, senior roles at Evotec.
Joined October 2023, medical background with cardiac imaging research experience and roles in strategy consulting and corporate venture capital at Philips.
Focus and check size from the firm's website. Website reachable as of Sept 2026.
A fit check scores your pitch against their thesis, stage and ticket. An email draft uses their real deals and thesis, not a template.